The Swedish Social Welfare Board has decided that a vaccine which helps prevent cervical cancer will be included in the series of vaccinations given to girls.
Get the full story...
Swedish Radio News reports that family wealth seems to determine which girls receive a vaccine that reduces the risk of some forms of cancer.
Get the full story...
The variety of human papilloma viruses that cause invasive cervical cancer cases worldwide are largely consistent across continents, according to a new study from the University of North Carolina at Chapel Hill.
Get the full story...
A second cervical cancer vaccine has passed a key clinical trial and its maker is seeking to use the vaccine in countries around the world. As VOA's Carol Pearson reports, more women may be able to use this new vaccine by drug giant GlaxoSmithKline than use the first cervical cancer vaccine, Gardisil.
Get the full story...
The Australian scientist who developed the world's first cervical cancer vaccine is now focusing on the disease in the developing world.
Get the full story...
Some U.S. state lawmakers are fighting a mandate requiring certain vaccinations for children, saying it encourages undesirable behavior. Getting vaccinated has become a more complicated process since the 18th century, when English scientist Edward Jenner first discovered a vaccine for smallpox.
Get the full story...
Cervical cancer is one of the most preventable cancers, and it can be diagnosed in the earliest stages with screening, leading to better treatment outcomes. Access to appropriate screening and treatment remains critical to the goal of eradicating cervical cancer as a threat to women. Unless every Texas woman can receive timely cervical cancer screening, treatment, and information on prevention, cervical cancer deaths will not be eliminated.
Read the full story
The news on cervical cancer vaccine tops the list of The Society for Women's Health Research, which announced the top 5 women's health stories of 2006. The list covers advances in research of particular interest to women and new sex-specific treatments and is selected by its scientific programs staff.
Read the full story